An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma

Taylor D. R.

Source: Eur Respir J 2010; 35: 1200-1202
Journal Issue: June
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Taylor D. R.. An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma. Eur Respir J 2010; 35: 1200-1202

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020



The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002

Is exhaled nitric oxide measurement useful in clinical practice?
Source: ISSN=ISSN 1810-6838, ISBN=, page=185
Year: 2006

Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019



Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020



Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019




Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005

Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011


Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Exhaled nitric oxide in childhood asthma: methodological issues and clinical applications
Source: Eur Respir Rev 2006; 15: 215-217
Year: 2006



The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 304s
Year: 2004

Exhaled nitric oxide as a predictor of exacerbations of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004

By how much can exhaled nitric oxide vary without a change in clinical status?
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017

Exhaled nitric oxide in specific challenge tests to assess occupational asthma
Source: Eur Respir J 2002; 20: 1532-1537
Year: 2002



Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005

Exhaled nitric oxide may predict future benefit in patients with poorly controlled asthma
Source: Annual Congress 2011 - Clinical application of exhaled biomarkers
Year: 2011